Reata pharmaceuticals has received a consensus rating of buy. The average price target is $74.88 with a high estimate of $227 and a low . Based on analysts offering 12 month price targets for reta in the last 3 months. Is currently listed on nasdaq under reta. (reta) stock quote, history, news and other vital information to help you with your stock trading and investing.
Based on analysts offering 12 month price targets for reta in the last 3 months.
Is currently listed on nasdaq under reta. (reta) stock quote, history, news and other vital information to help you with your stock trading and investing. The average price target is $74.88 with a high estimate of $227 and a low . One share of reta stock can currently be purchased for approximately $28.71. 4.3 analyst's opinion · consensus rating. Stock analysis for reata pharmaceuticals (reta) including real time stock price, quotes, news, full analysis, historical charts, . Real time reata pharmaceuticals, inc. Down from us$226, the current price target is an average from 8 analysts. Feb 1, 2022 9:37 a.m. Stock is down 58% over . Based on analysts offering 12 month price targets for reta in the last 3 months. Reata pharmaceuticals has received a consensus rating of buy. Find the latest reata pharmaceuticals, inc.
Feb 1, 2022 9:37 a.m. (reta) stock quote, history, news and other vital information to help you with your stock trading and investing. Is currently listed on nasdaq under reta. One share of reta stock can currently be purchased for approximately $28.71. Reata pharmaceuticals has received a consensus rating of buy.
4.3 analyst's opinion · consensus rating.
(reta) stock price quote, stock graph, news & analysis. 4.3 analyst's opinion · consensus rating. Stock analysis for reata pharmaceuticals (reta) including real time stock price, quotes, news, full analysis, historical charts, . The average price target is $74.88 with a high estimate of $227 and a low . Stock is down 58% over . One share of reta stock can currently be purchased for approximately $28.71. Reata pharmaceuticals has received a consensus rating of buy. (reta) stock quote, history, news and other vital information to help you with your stock trading and investing. Down from us$226, the current price target is an average from 8 analysts. Real time reata pharmaceuticals, inc. New target price is 270% above last closing price of us$54.42. Based on analysts offering 12 month price targets for reta in the last 3 months. Find the latest reata pharmaceuticals, inc.
Is currently listed on nasdaq under reta. Based on analysts offering 12 month price targets for reta in the last 3 months. Down from us$226, the current price target is an average from 8 analysts. One share of reta stock can currently be purchased for approximately $28.71. Stock is down 58% over .
Feb 1, 2022 9:37 a.m.
(reta) stock quote, history, news and other vital information to help you with your stock trading and investing. Find the latest reata pharmaceuticals, inc. One share of reta stock can currently be purchased for approximately $28.71. Feb 1, 2022 9:37 a.m. Real time reata pharmaceuticals, inc. (reta) stock price quote, stock graph, news & analysis. 4.3 analyst's opinion · consensus rating. New target price is 270% above last closing price of us$54.42. Reata pharmaceuticals has received a consensus rating of buy. Stock is down 58% over . Based on analysts offering 12 month price targets for reta in the last 3 months. Is currently listed on nasdaq under reta. Down from us$226, the current price target is an average from 8 analysts.
Reata Pharmaceuticals Stock Analysis - Reta Stock Plummets As Fda Waffles On Kidney Disease Drug Investor S Business Daily : Feb 1, 2022 9:37 a.m.. Stock analysis for reata pharmaceuticals (reta) including real time stock price, quotes, news, full analysis, historical charts, . The average price target is $74.88 with a high estimate of $227 and a low . 4.3 analyst's opinion · consensus rating. Find the latest reata pharmaceuticals, inc. Stock is down 58% over .